Search research articles
Contact Us
Filters
Showing results (271-280 of 312) with videos related to
Page
of 32
Sort By:
European Heart Journal
|
September 3, 2015
ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia
John J P Kastelein, Henry N Ginsberg, Gisle Langslet, et al.
Diabetes Care
|
December 29, 2006
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association
John B Buse, Henry N Ginsberg, George L Bakris, et al.
Journal of Alzheimer'S Disease : JAD
|
August 30, 2021
Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial
Jeffrey Cummings, Gregory G Schwartz, Stephen J Nicholls, et al.
The Journal of Biological Chemistry
|
August 27, 2014
Cardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure
Li Liu, Chad M Trent, Xiang Fang, et al.
Journal of the American College of Cardiology
|
January 13, 2018
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis
Sotirios Tsimikas, Sergio Fazio, Keith C Ferdinand, et al.
JAMA
|
August 29, 2017
Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk
Brian A Ference, John J P Kastelein, Henry N Ginsberg, et al.
The American Journal of Cardiology
|
July 12, 2007
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods
, John B Buse, J Thomas Bigger, et al.
The Journal of Biological Chemistry
|
December 30, 2016
Normalization of Hepatic Homeostasis in the <i>Npc1</i> Mouse Model of Niemann-Pick Type C Disease Treated with the Histone Deacetylase Inhibitor Vorinostat
Andrew B Munkacsi, Natalie Hammond, Remy T Schneider, et al.
Rapid Communications in Mass Spectrometry : RCM
|
May 18, 2013
Measurement of apo(a) kinetics in human subjects using a microfluidic device with tandem mass spectrometry
Haihong Zhou, Jose Castro-Perez, Michael E Lassman, et al.
JAMA
|
January 30, 2019
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease
Brian A Ference, John J P Kastelein, Kausik K Ray, et al.
Page
of 32
Search research articles
Search
Showing results (271-280 of 312) with videos related to
Sort By:
Page
of 32
European Heart Journal
|
September 3, 2015
ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia
John J P Kastelein, Henry N Ginsberg, Gisle Langslet, et al.
Diabetes Care
|
December 29, 2006
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association
John B Buse, Henry N Ginsberg, George L Bakris, et al.
Journal of Alzheimer'S Disease : JAD
|
August 30, 2021
Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial
Jeffrey Cummings, Gregory G Schwartz, Stephen J Nicholls, et al.
The Journal of Biological Chemistry
|
August 27, 2014
Cardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure
Li Liu, Chad M Trent, Xiang Fang, et al.
Journal of the American College of Cardiology
|
January 13, 2018
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis
Sotirios Tsimikas, Sergio Fazio, Keith C Ferdinand, et al.
JAMA
|
August 29, 2017
Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk
Brian A Ference, John J P Kastelein, Henry N Ginsberg, et al.
The American Journal of Cardiology
|
July 12, 2007
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods
, John B Buse, J Thomas Bigger, et al.
The Journal of Biological Chemistry
|
December 30, 2016
Normalization of Hepatic Homeostasis in the <i>Npc1</i> Mouse Model of Niemann-Pick Type C Disease Treated with the Histone Deacetylase Inhibitor Vorinostat
Andrew B Munkacsi, Natalie Hammond, Remy T Schneider, et al.
Rapid Communications in Mass Spectrometry : RCM
|
May 18, 2013
Measurement of apo(a) kinetics in human subjects using a microfluidic device with tandem mass spectrometry
Haihong Zhou, Jose Castro-Perez, Michael E Lassman, et al.
JAMA
|
January 30, 2019
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease
Brian A Ference, John J P Kastelein, Kausik K Ray, et al.
Page
of 32